Literature DB >> 15770592

Cytokines and growth factors involved in peritoneal fibrosis of peritoneal dialysis patients.

K-H Oh1, P J Margetts.   

Abstract

Peritoneal fibrosis is initiated by exposure of peritoneal tissues to numerous harmful agents encountered during peritoneal dialysis. These agents interact with cells within the peritoneum to induce growth factors and cytokines that are important in the initiation, progression and maintenance of fibrosis. Some of the mediators implicated in the pathogenesis of peritoneal fibrosis include transforming growth factor (TGF) beta, connective tissue growth factor (CTGF), fibroblast growth factors (FGF), and platelet derived growth factor (PDGF).

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15770592     DOI： 10.1177/039139880502800208

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN： 0391-3988            Impact factor:   1.595


  6 in total

Review 1.  Pharmacologic targets and peritoneal membrane remodeling.

Authors:  Karima Farhat; Andrea W D Stavenuiter; Rob H J Beelen; Piet M Ter Wee
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 2.  Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients.

Authors:  Raymond T Krediet; Alena Parikova
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-15       Impact factor: 10.614

3.  Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.

Authors:  Zhi-Dong Lv; Di Na; Fu-Nan Liu; Zong-Min Du; Zhe Sun; Zhen Li; Xiao-Yang Ma; Zhen-Ning Wang; Hui-Mian Xu
Journal:  J Exp Clin Cancer Res       Date:  2010-10-29

4.  A crosstalk between the Smad and JNK signaling in the TGF-β-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells.

Authors:  Qinghua Liu; Yu Zhang; Haiping Mao; Wei Chen; Ning Luo; Qin Zhou; Wenfang Chen; Xueqing Yu
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

5.  Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis.

Authors:  Bo Young Nam; Jung Tak Park; Young Eun Kwon; Jung Pyo Lee; Jong Ha Jung; Youndong Kim; Seonghun Kim; Jimin Park; Jae Eun Um; Meiyan Wu; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang
Journal:  Mol Ther Nucleic Acids       Date:  2017-05-08

6.  Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.

Authors:  Kang-Han Liu; Nan Zhou; Yan Zou; Yi-Ya Yang; Sha-Xi OuYang; Yu-Mei Liang
Journal:  Med Sci Monit       Date:  2019-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.